In two trials of 1912 infants in Uganda and Nepal, two-dose DTwP-Hib-HepB schedules failed non-inferiority vs the WHO 6-10-14 week schedule for pre-booster pertussis antibodies, except FHA in Nepal. Delayed three-dose schedules (exploratory) gave similar or higher responses.
RCTn = 1,912
Bijukchhe et al. Optimising DTwP-containing vaccine infant immunisation schedules in Uganda and Nepal (OptImms): two open-label, non-inferiority, randomised controlled trials